Search results
Results From The WOW.Com Content Network
Milnacipran was found to improve impulse control in rats, which has been linked to its activation of D 1-like receptors in the infralimbic cortex. [6] However, high doses of milnacipran did not show this effect, likely because of increased dopamine in the nucleus accumbens. [7] Depression has been associated with increased impulsivity.
This is a list of psychiatric medications used by psychiatrists and other physicians to treat mental illness or distress. The list is ordered alphabetically according to the condition or conditions, then by the generic name of each medication. The list is not exhaustive and not all drugs are used regularly in all countries.
Although compulsive buying falls under the category of Impulse-control disorder – Not Otherwise Specified in the DSM-IV-TR, some researchers have suggested that it consists of core features that represent impulse-control disorders which includes preceding tension, difficult to resist urges and relief or pleasure after action.
The 2025 Chevrolet Equinox RS AWD has an 11-inch instrument cluster and 11.3-inch touch screen. The steering column has a simple gear selector for park, reverse and drive.
Body-focused repetitive behavior (BFRB) is an umbrella name for impulse control [1] behaviors involving compulsively damaging one's physical appearance or causing physical injury. [2] Body-focused repetitive behavior disorders (BFRBDs) in ICD-11 is in development. [3] BFRB disorders are currently estimated to be under the obsessive-compulsive ...
The system was a $2700 option on my 2024 Equinox EV 2LT tester, but speccing it on the 2025 model requires choosing additional options that push the overall cost of the car up to $49,750—nearly ...
Brexpiprazole, sold under the brand name Rexulti among others, is an atypical antipsychotic medication used for the treatment of major depressive disorder, schizophrenia, and agitation associated with dementia due to Alzheimer's disease.
The gene therapy will compete with Australia-based CSL Behring’s Hemgenix, a similar treatment that won FDA approval for hemophilia B in 2022. That drug has a similar list price of $3.5 million ...